Repurposed benzydamine targeting CDK2 suppresses the growth of esophageal squamous cell carcinoma.
Zhou Y, He X, Jiang Y, Wang Z, Yu Y, Wu W, Zhang C, Li J, Guo Y, Chen X, Liu Z, Zhao J, Liu K, Dong Z.
Zhou Y, et al. Among authors: he x.
Front Med. 2023 Apr;17(2):290-303. doi: 10.1007/s11684-022-0956-8. Epub 2022 Dec 29.
Front Med. 2023.
PMID: 36580233